Skip to main content

What the FDA labels say about taking them together

Griseofulvin and verteporfin

Verteporfin's FDA label of August 27, 2025 names griseofulvin in its drug interactions section; the griseofulvin label PlainMeds reads does not name verteporfin. The verteporfin label: “Other photosensitizing agents could increase the potential for skin photosensitivity reactions.”

Check it at the source: the griseofulvin FDA label on DailyMed (effective December 10, 2025); the verteporfin FDA label on DailyMed (effective August 27, 2025, Bausch Health US LLC).

What does the griseofulvin label say about verteporfin?

Griseofulvin's label (effective December 10, 2025) does not name verteporfin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Ultramicrosize Griseofulvin), Chartwell RX, LLC., effective December 10, 2025 (SPL set efb8a660-802c-4ca6-bbff-ad7b48b91aef), via openFDA; the full label on DailyMed

What does the verteporfin label say about griseofulvin?

Verteporfin label, drug interactions

Other photosensitizing agents (e.g., tetracyclines, sulfonamides, phenothiazines, sulfonylurea hypoglycemic agents, thiazide diuretics and griseofulvin) could increase the potential for skin photosensitivity reactions.

Source: FDA drug label (Visudyne), Bausch Health US LLC, effective August 27, 2025 (SPL set 952f4c80-50b1-4308-9ee6-311ffefb13df), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Griseofulvin generic labelers
0Verteporfin generic labelers
GriseofulvinVerteporfin
Labeled forFungal infectionsn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$3.74 per tablet 250 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?